What's breaking now, across thousands of outlets.
KymaThera gets $80M: The San Diego biotech raised the Series B to develop its pan-mutant selective PI3Kα inhibitor called K-1728. The experimental oral medicine is slated to enter Phase 1 this ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
New York Gov. Kathy Hochul (D) on Monday declared the first statewide disaster emergency this year over a measles outbreak that has sickened more than 100 people.
The Kenya Medical Practitioners, Pharmacists and Dentists Union (KMPDU) has called for urgent measures to protect healthcare workers following the confirmation of an imported Ebola Virus Disease case…
Colorectal cancer in young people is often diagnosed at an advanced stage, with researchers finding most patients age 21 or younger already had Stage III or IV disease.
For many Ghanaian families, a serious illness can quickly turn into a financial crisis, with prolonged treatment forcing some to exhaust their savings, rely on relatives or sell personal belongings to…
The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and PTSD
Pimple patches may improve a spot overnight, yet irritation risks and weak evidence suggest they’re likely not a substitute for acne treatment.
